Fundz

Self.co raises €2.56M to improve molecular allergy testing technology and expand markets, led by Iron Wolf Capital.

PRIVATENov 11, 2025

Amount Raised

€2.56 Million

Round Type

Seed

BiotechnologyHealth Carehospital & health care

Investors

NGL VenturesCoinvestIron Wolf Capital

Description

Self.co, a digital health company focused on allergy and food intolerance management, has secured €2.56 million in a funding round, including a €1.36 million grant. The round was led by Iron Wolf Capital, included participation from Coinvest and NGL Ventures, and several angel investors. The funding will enhance testing technology and support market expansion. Allergies affect a significant portion of the global population, and Self.co aims to address the diagnostic challenges.

Quick answer

Self.co raised €2.56 Million in a Seed round, dated November 11, 2025. Investors: NGL Ventures, Coinvest and Iron Wolf Capital.

How much did Self.co raise?
Self.co raised €2.56 Million in a Seed round on November 11, 2025.
Who invested in Self.co?
NGL Ventures, Coinvest and Iron Wolf Capital are named as investors in this round.
What does Self.co do?
Self.co is a digital health company focused on helping individuals understand and manage allergies and food intolerances through innovative testing solutions.
Where is Self.co based and how big is it?
Fundz records about 35 employees.
Who are the decision-makers at Self.co?
Fundz holds 1 contact at Self.co. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in hospital & health care and Biotechnology around the same time

Companies in the same sectors as Self.co that raised within 45 days of this round, from Fundz verified event records.

  • Circulate Health raised $7M on December 3, 2025.
  • CustoMED raised $6M (Seed) on October 29, 2025.
  • Kneu Health raised $5.6M (Seed) on October 9, 2025.
  • Kashiv BioSciences raised $72M (Debt Financing) on December 23, 2025.
  • Initiate raised an undisclosed amount (Private Equity) on December 23, 2025.
  • Vyriad raised $25M (Series B) on December 23, 2025.

Who to call at Self.co, and when

A new round usually means Self.co is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Self.co raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Self.co, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Self.co. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Self.co

About

Self.co is a digital health company focused on helping individuals understand and manage allergies and food intolerances through innovative testing solutions. It offers proprietary microarray tests that analyze allergens and food sensitivities using simple blood samples taken at home. By eliminating intermediaries, Self.co provides laboratory-grade testing at a fraction of traditional costs. Their service includes personalized avoidance plans and connections to healthcare providers for relevant treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Self.co raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Self.co's next move

See what Strategic adds

Self.co raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.